drugset / Trial / NCT05010356

Insulin Sensitivity After Breast Cancer

NCT05010356

Recruiting 24 enrolled University of Copenhagen
Non-randomizedParallel-groupOpen-labelBasic science

Summary

Epidemiological studies have revealed that 60-80% of women with breast cancer (BC) develop metabolic disorders that are similar to those observed in conditions like type 2 diabetes. These metabolic disorders, including insulin resistance, obesity, hyperinsulinemia, and glucose intolerance, are associated with increased BC recurrence and mortality. Skeletal muscle is the major site of glucose uptake in humans. The aims of the present project are to 1) determine the involvement of insulin resistance in skeletal muscle in the metabolic disorders prevalent in BC survivors, 2) identify BC-and/or treatment-induced molecular changes in skeletal muscle from BC survivors .

Timeline

Start
2021-08
Primary completion
2022-12
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Protein / enzyme biologic 1.4 unknown